Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...
A new weight loss drug target may help reduce appetite and burn calories without causing sickness, research suggests. The ...
With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...
Pemvidutide is a promising GLP-1/glucagon dual receptor agonist that focuses on fundamental metabolic processes to stimulate ...
Amgen has rebuffed claims made by an analyst suggesting that its obesity drug MariTide is associated with reductions in bone ...
Just seven months after unveiling with $290 million, obesity biotech Metsera is back with another $215 million.
WEDNESDAY, Nov. 13, 2024 (HealthDay News) -- The blockbuster GLP-1 drug semaglutide ( Ozempic, Wegovy) could curb drinking ...
Early studies show a drug can effectively 'switch on' particular cells within the nervous system that play an important role ...
Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...
Whether these departments get the money will be decided later, but the Scene listened in on requests from the Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback